This meta-analysis found that, compared with conventional radiotherapy, surgery improved ability to walk for people with metastatic cancer in the spine. The authors concluded that surgery should be the primary treatment, with radiation as adjuvant therapy. The comparison between radiotherapy and surgery was indirect and based on uncontrolled observational studies; hence, the conclusions should be treated with caution.
Authors' objectives
To compare the effect of surgery versus conventional radiotherapy on the ambulatory status of people with metastatic spinal epidural disease.
Searching
PubMed was searched for articles published in the English language between 1980 and August 2003; the search terms were reported. In addition, the authors handsearched journals and examined the reference lists of review papers.
Study selection

Study designs of evaluations included in the review
Retrospective or prospective cohort studies were eligible for inclusion.
Specific interventions included in the review
Studies of radiotherapy or surgery were eligible for inclusion. Surgery involved decompression of the spinal cord circumferentially, followed by reconstruction and stabilisation, with radiation given either pre-operatively, postoperatively, or not at all. Studies of radiotherapy had to report the cumulative radiation dose and schedule. Most of the included studies involved standard external beam radiation therapy (usually 2,800 to 3,200 cGy total dose divided over 7 to 12 days).
Participants included in the review
Eligible studies included adults with symptomatic metastatic spinal disease. In several of the surgery studies, the participants had previously received radiotherapy. The average age was 56 years for surgery patients and 63 years for radiotherapy. Forty-eight per cent of the surgery patients and 51% of the radiotherapy patients were women. Two thirds had metastatic lesions located primarily in the thoracic spine (68% in both the surgery and radiotherapy studies). The primary cancer sites were predominantly breast, renal, lung , and prostate. Two per cent of participants had primary spinal bone tumours other than metastatic disease; these did not conform to the inclusion criteria but could not be separated in the data analysis.
Outcomes assessed in the review
To be eligible for inclusion, the studies had to report on ambulatory status before and after treatment and to include data on age, gender, site of primary disease and site of disease within the spine. The primary outcome of the review was ambulation: success or rescue, defined as the proportion of people ambulatory after treatment and the proportion regaining ambulatory function, respectively. Participants were considered ambulatory if they could walk with or without assistance. Secondary outcomes (pain, sphincter function, survival, complications and local recurrence) were also assessed.
How were decisions on the relevance of primary studies made?
